Adeshwar Meditex Ltd (ADESHWAR) — shareholding pattern, promoter holding, financials and share price
About Adeshwar Meditex Ltd (ADESHWAR)
Adeshwar Meditex Ltd operates in the Healthcare Research, Analytics & Technology industry, within the Healthcare sector. It trades on the NSE as ADESHWAR and on the BSE under scrip code 543309. Its ISIN is INE0H8J01015.
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of sterile surgical wound dressings and medical disposables [1]
Adeshwar Meditex Limited is a major manufacturer and exporter specializing in sterile surgical wound dressings and medical disposables.
The company, established in 2007 and public since 2021, provides a wide range of medical items including first aid kits tailored for hospitals and diverse industries.
Listed peers in Healthcare Research, Analytics & Technology: Bilcare Ltd, Jeevan Scientific Technology Ltd, Globalspace Technologies Ltd, Novelix Pharmaceuticals Ltd, Vanta Bioscience Ltd, Docmode Health Technologies Ltd.
Valuation & Returns
At ₹17 a share, Adeshwar Meditex Ltd (ADESHWAR) was valued at a price-to-earnings ratio of 12.47x against an industry P/E of 61.73x and a price-to-book of 1.44x on a book value of ₹10.59 per share. Solomo computes return on equity of 3.35% and return on capital employed of 5.21% from filed results.
- P/E
- 12.47x
- Industry P/E
- 61.73x
- P/B
- 1.44x
- EPS (TTM)
- ₹1.43
- Book value / share
- ₹10.59
- ROE
- 3.35%
- ROCE
- 5.21%
- ROA
- 2.57%
- Debt / equity
- 0.54x
- Dividend yield
- 0%
- EBITDA margin
- 6.44%
- 52-week range
- ₹13 – ₹21.8
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2022In the year ended Mar 2022, Adeshwar Meditex Ltd (ADESHWAR) reported revenue of ₹64.76 crore, net profit of ₹0.79 crore and earnings per share of ₹0.55. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹26.05 crore and net profit ₹0.53 crore (standalone).
| Metric | Mar 2022 |
|---|---|
| Revenue (₹ cr) | 64.76 |
| Net profit (₹ cr) | 0.79 |
| EPS (₹) | 0.55 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 8.33% | 8.94% | 4.83% |
| Profit growth | -0.48% | 37.60% | 2.99% |
| Stock price CAGR | -8% | -10% | -6% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 57.68% of Adeshwar Meditex Ltd (ADESHWAR). Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2021.
Largest disclosed public shareholders in Mar 2026: ASHALATA B RAUT 6.11%, MAHAVEERPRASAD NANDLAL AGARWAL 3.04%, BABY DATTATRAY CHAVAN 2.77%, SANJAY SINGH 2.26%, SHARDA RASIKLAL MEHTA 1.95%, AMISH RASIKLAL MEHTA 1.87%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 57.68% | - | - | - | 42.32% |
| Sep 2025 | 57.55% | - | - | - | 42.45% |
| Mar 2025 | 57.55% | - | - | - | 42.45% |
| Sep 2024 | 57.55% | - | - | - | 42.45% |
| Mar 2024 | 42.65% | - | - | - | 57.35% |
| Sep 2023 | 42.65% | - | - | - | 57.35% |
| Mar 2023 | 42.65% | - | - | - | 57.35% |
| Sep 2022 | 42.65% | - | - | - | 57.35% |